[ADVERT]
Share Name Share Symbol Market Type Share ISIN Share Description
Xaar Plc LSE:XAR London Ordinary Share GB0001570810 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  3.20 1.73% 188.40 188.00 189.20 189.60 187.00 187.00 93,293 11:23:47
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Technology Hardware & Equipment 48.0 -4.3 -15.2 - 147

Xaar Share Discussion Threads

Showing 5901 to 5923 of 5925 messages
Chat Pages: 237  236  235  234  233  232  231  230  229  228  227  226  Older
DateSubjectAuthorDiscuss
16/9/2021
07:24
Simon Thomson in Investors' Chronicle: The price has since pulled back close to my last entry point (185p) on profit taking which means that Xaar is now rated on an enterprise valuation to cash profit multiple of 9 for 2023, hardly excessive for a recovery stock. I am tweaking my target up slightly from 220p to 230p and continue to rate the shares a buy. https://www.investorschronicle.co.uk/ideas/2021/09/15/bargain-shares-a-roadmap-for-recovery/ (Search on text to access whole article)
zho
15/9/2021
09:41
Investec raises its target to 280p. https://twitter.com/SCSWSharewatch/status/1437766835718574080?s=20
northwards
14/9/2021
17:40
Seems the uncertain outlook is to blame. Similar article in sharecast to the one below. hxxps://www.sharesmagazine.co.uk/news/shares/xaar-sinks-12-on-wider-first-half-loss Inkjet printing technology specialist Xaar (XAR) fell 12.3% to 190p after posting a deeper first half loss as rising revenue was offset by increased expenses, including higher R&D spending. This, plus a highly caveated outlook statement, appeared to prompt fears of an eventual profit warning, despite the company sticking with full year guidance for now. Often a weak first half creates a situation where a company struggles to catch up and is eventually forced to guide full-year expectations lower. Pre-tax losses for the six months through June amounted to £5.6 million, compared to £4.8 million for the same six month period a year earlier. Revenue rose 11% to £26.3 million, which Xaar said was in line with its expectations. 3D PRINTING SALE TAKES LONGER THAN EXPECTED The company said it would announce details of a planned sale of its 3D-printing division soon, while admitting the process had taken longer than expected. Notwithstanding the proceeds from any sale of this business the company was sitting on net cash of £17.1 million. ‘We are pleased with our continued strong performance which, despite challenging market conditions, demonstrates the success of our strategy and underlying strength of the business,’ chief executive John Mills said. ‘Our foundations remain strong, as we continue to gain new customers and positively re-engage in our core markets.’ ‘The Covid-19 pandemic continues to cause disruption for business, however we are determined to minimise interruption to the supply of printheads, and we are well-positioned to withstand further volatility caused by the pandemic.’
dr biotech
14/9/2021
16:21
Its MRCH they are up today I think
malcolmmm
14/9/2021
16:17
Malcolmmm, thanks. What's the epic for the Merchants board?
farmergeorge
14/9/2021
15:59
Yes just bought a few more, see how they finish today
malcolmmm
14/9/2021
15:57
The more of these I buy the lower the price goes, hopefully no bad news in the pipeline.
investoree
14/9/2021
14:48
farmergeorge take a look on the MERCHANTS board . Its been known for some time that we are cheap .A lot of funds think we are cheap A Latter says despite excellent gains made by fund managers since the market lows, UK equities continue to operate at a 40 per cent discount to their peers - a 30 year-low, so there is still a lot of catching up to do.
malcolmmm
14/9/2021
14:24
Thank montynj, That's a tweet from SCSW, in case anyone wondered.
zho
14/9/2021
14:20
Investec note out on #XAR "Revenue was ahead, on strong Ceramics & Glass volumes. The sale of Xaar 3D expected in 4Q21. Investec'sTP up by 30% to 280p, highlighting the profit trajectory and self-help."
montynj
14/9/2021
14:13
Malcommm, ok noted. Fingers crossed it doesn't spike down even more or you could get caught. Who's 'they'? Thanks.
farmergeorge
14/9/2021
13:55
farmergeorge no stoploss at present as they could swing about for awhile , I have been caught out with a 12% downward split second spike before.Wait to they stabilise imo. But never know with the stock market. But they recon UK shares are cheap
malcolmmm
14/9/2021
12:56
This looks like the sort of publication that you'd hide inside the cover of a porno mag to stop embarassing yourself. Still its good that they are getting it out there today. I've added a small amount here on the dip. Sold out of Staffline thats also had a wobble on results. Hope thats the right decision. hxxps://www.labelsandlabeling.com/news/new-products/xaar-introduces-irix-printhead
dr biotech
14/9/2021
12:26
Malcolmmm, what stop loss?
farmergeorge
14/9/2021
12:07
IMHO it's a sign of a highly (over?) valued market that it's better to travel than to arrive. STAF had the same treatment. XAR is still a recovery situation, yet to show complete recovery. The sale of 3D hasn't happened yet & we don't know the outcome of that in £££ terms, which means directors can't show confidence by buying shares. The market needs to see this year's H2 and the sales performance of the much publicised new aqueous print heads before revenues and profits are confirmed. ON THE PLUS SIDE... Progress is good, product investment has been focused, future sales look promising. The 2021 Interim Results Webcast is very positive; https://www.youtube.com/watch?v=OkXYyALZLOg I still believe the story & not changed my holding/position. Target = £5, patience required. NAI, IMHO, DYOR!
napoleon 14th
14/9/2021
11:54
I did and a spread bet .Usually takes a week or two to recover after results.
malcolmmm
14/9/2021
11:09
August SCSW: "Xaar (becomes H2 nap no.7)" @233p September SCSW: "T Clarke is on GP3’s buy list and so too is Xaar." I have doubled up today with these. Could be an easy 15% to get back to 233p, just for starters. Maybe SCSW took a position today in their GP.
dougmachin
14/9/2021
10:55
We’re pleased to report great progress in our half year results. We are regaining customers, growing revenue and delivering new products, all with the goal of bringing Xaar back to profitability Https://www.linkedin.com/posts/xaar_2021-interim-results-activity-6843467497899884544-egGu
bigbigdave
14/9/2021
10:48
Confident presentation. Announcement on sale of 3D business "imminent".
zho
14/9/2021
10:35
Adding more
nw99
14/9/2021
10:00
Trust me to pick the dog again. Another one to stick on the backbook
simmsc
14/9/2021
08:44
Looks like sale of 3D business is imminent. Lets see impact of analysis call shortly. Covid growing in Asia is an issue for all of us and a worry.
northwards
14/9/2021
08:24
I'm adding too
montynj
Chat Pages: 237  236  235  234  233  232  231  230  229  228  227  226  Older
ADVFN Advertorial
Your Recent History
LSE
XAR
Xaar
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210921 11:00:18